AI app aims to keep heart patients out of the hospital

NCT ID NCT06686056

Completed Disease control Sponsor: China National Center for Cardiovascular Diseases Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether an artificial intelligence (AI)-enhanced mobile app can help people with coronary heart disease manage their health after leaving the hospital. Over 1,100 participants used the app to track health metrics, receive medication reminders, and get lifestyle tips, while a comparison group received usual care. The main goal was to see if the app helped lower bad cholesterol (LDL-C) within three months, along with improving blood pressure, blood sugar, and medication adherence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-enhanced mobile health app (AIM-CHD)
What this could lead to: If it works, this could provide an effective, scalable way for people with heart disease to manage their condition at home and reduce future heart problems.
What could go wrong: This is a single-center study with 1100 participants, so results may not apply to everyone. The app's success depends on user engagement and may not work for those less comfortable with technology.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SECONDARY PREVENTION OF CORONARY HEART DISEASE

Contacts and locations

Locations

Fuwai Hospital, Chinese Academy of Medical Sciences/National Center for Cardiovascular Diseases

Beijing, Beijing Municipality, 100037, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.